NOT-HL-23-105: Notice of Change to RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)"

Notice of Change to RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)"

Notice Number:

NOT-HL-23-105

Key Dates

Release Date:

August 8, 2023

Related Announcements

June 21, 2023 - The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed). See NOFO RFA-HL-24-011.
June 21, 2023 - The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional). See NOFO RFA-HL-24-010.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to alert potential applicants that an additional, optional attachment for Glossary of Abbreviations may be included in Section IV for RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)".

Section IV. 2. Application and Submission Information, SF424(R&R) Other Project Information, Other Attachments

Modified to Include New Other Attachment (in bold italics):

6. Glossary of Abbreviations - Optional

This attachment may only be used to list and define the abbreviations used throughout the application. If included, this must be provided as an attachment named “Abbreviations.pdf” and cannot exceed 2 pages.

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

Nancy L. DiFronzo, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: nancy.difronzo@nih.gov

Lori A. Henderson, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5930
Email: hendersonlori@mail.nih.gov